Merck (MRK) Shuts Down Covid Vaccine Program After Lackluster Data – Bloomberg

Merck & Co. is discontinuing development of its two experimental Covid-19 vaccines after early trial data showed they failed to generate immune responses comparable to a natural infection or existing vaccines.

Merck (MRK) Shuts Down Covid Vaccine Program After Lackluster Data – Bloomberg